SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-19-005659
Filing Date
2019-08-26
Accepted
2019-08-26 16:00:13
Documents
4
Period of Report
2019-08-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_082619.htm 8-K 46692
2 EXHIBIT 3.1 exh_31.htm EX-3.1 15832
3 EXHIBIT 10.1 exh_101.htm EX-10.1 257637
4 EXHIBIT 10.2 exh_102.htm EX-10.2 25202
  Complete submission text file 0001171843-19-005659.txt   346834
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 191052793
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences